Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy

Marion Dalmasso1,2, Ronan Strain1,2, Horst Neve3

  • 1School of Microbiology, University College Cork, Cork, Ireland.

Plos One
|June 10, 2016
PubMed

Insights

New bacteriophages (phages) show promise against multi-drug resistant bacteria. A phage cocktail effectively inhibited E. coli growth, reduced biofilms, and prevented resistance, offering a potential biocontrol strategy.

Area of Science:

  • Microbiology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Multi-drug resistant bacteria pose a significant global health threat.
  • Bacteriophages (phages) are viruses that infect bacteria and are being re-evaluated as antimicrobial agents.
  • Phage therapy offers a potential alternative to conventional antibiotics.

Purpose of the Study:

  • To isolate and characterize novel bacteriophages from human fecal samples.
  • To evaluate the lytic activity of isolated phages against E. coli.
  • To assess the efficacy of phages in combination with ciprofloxacin and their ability to prevent resistance.

Main Methods:

  • Isolation of coliphages from human fecal samples.
  • Phenotypic and genomic characterization of isolated phages.
  • Assessment of lytic activity against E. coli biofilms and in combination with ciprofloxacin.

Main Results:

  • Three novel coliphages (ɸAPCEc01, ɸAPCEc02, ɸAPCEc03) were isolated.
  • A phage cocktail completely inhibited E. coli growth and reduced biofilm formation.
  • The phage cocktail prevented the emergence of phage-resistant mutants, unlike single phages.
  • Combination therapy with ciprofloxacin and phages inhibited E. coli and prevented resistance.

Conclusions:

  • The isolated bacteriophages demonstrate significant lytic activity against E. coli.
  • A phage cocktail is effective in controlling E. coli growth and biofilms.
  • Phage therapy, alone or in combination with antibiotics, is a promising strategy to combat E. coli infections and prevent resistance.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
79.7K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
69.3K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.3K
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
5
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.3K
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
2